FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says
9 hours ago
1
The institution plans to refile its exertion for its cistron therapy for a fatal encephalon illness aft the FDA dropped demands to springiness a placebo to immoderate survey subjects.